Back to News
Market Impact: 0.4
Xencor, Inc. Reports Third Quarter 2026 Financial Results and Outlines Clinical Pipeline Plans
Source: Nasdaq
Corporate EarningsHealthcare & BiotechCompany Fundamentals
Xencor reported Q3 2026 revenue of $116.5 million, up from $21.0 million in Q3 2025. Net income attributable to Xencor was $39.4 million; the article excerpt also reports $0.50 per share but cuts off before specifying the full basis.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.55
Ticker Sentiment
XNCR0.70
More News
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- Qualcomm slides 9% after earnings, leading post-election chip stock sell-off
- Costco is taking aim at its May record high — how it got here and where's it going
- Neocloud IREN says $4 billion in annualized revenue being delayed due to customer request
- Tapestry CEO on Earnings Beat, Consumer Outlook